I normally don’t blog about other blogs, but today I break the rule to weigh in on speculation that Kleiner Perkins Caufield & Byers is turning away from cleantech. This shift in focus is suggested in a Fortune piece claiming that the storied VC firm is refocusing on its so-called sweet spot: the Internet. The [...]

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has filed for a $100 million IPO. It plans to trade under ticker symbol AMRS, with Goldman Sachs, J.P. Morgan and Morgan Stanley serving as co-lead underwriters. The company reports $64 million in 2009 revenue, compared to $14 million in 2008. [...]

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has raised $47.8 million from Temasek Holdings. The company previously raised just under $200 million from Kleiner Perkins, Khosla Ventures, TPG Biotechnology, Votorantim Novos Negocios, Advanced Equities Inc., DAG Ventures, Grupo Cornélio Brennand, Naxos UK, The Westly Group and Stratus Group.

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has secured $24.75 million of a $62 million Series C round, according to a regulatory filing. The company previously raised more than $120 million, from firms like Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPG Biotech. www.amyrisbiotech.com

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has expanded its Series B round from $70 million to around $90 million, according to a regulatory filing. So far, it has called down just over $50 million of that amount. No new investors are listed. DAG Ventures was the original round [...]